DR. GARETH M. C. LEMA MD, PHD
Prescription History 1982802476
Ophthalmology - Retina Specialist in New York, NY
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. GARETH M. C. LEMA MD, PHD, an active Retina Specialist specialist practicing in New York, NY. Our medical registry currently tracks 10 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 292 documented patient claims. Among these therapy options, the most frequently utilized medication is Ilevro, which accounts for 61 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other NY PrescribersVs. NY Avg |
|---|---|---|---|
| IlevroNepafenac | 61 | $388.56 | ▲ More than typical |
About Ilevro: This medication is used to relieve eye pain, irritation, and redness following cataract eye surgery. Show more ▾ Nepafenac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking certain natural substances (prostaglandins) in your body that cause pain and swelling. In 2023, this provider wrote 61 Medicare prescriptions for Ilevro, about 1.4 times the volume of the typical New York prescriber of this medication (43). Medicare paid an average of $388.56 per fill, versus $360.67 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 72 30-Day Fills standardized to 30-day supplies 1,930 Days of Medication total across all patients in 2023 | |||
| Latanoprost | 53 | $12.24▼ below NY avg | ▼ Less than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 53 Medicare prescriptions for Latanoprost, about a third of the volume of the typical New York prescriber of this medication (149). Medicare paid an average of $12.24 per fill, versus $20.93 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 74.2 30-Day Fills standardized to 30-day supplies 2,021 Days of Medication total across all patients in 2023 | |||
| Prednisolone Acetate | 37 | $55.97 | ▼ Less than typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 37 Medicare prescriptions for Prednisolone Acetate, about a quarter of the volume of the typical New York prescriber of this medication (135). Medicare paid an average of $55.97 per fill, versus $52.63 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 50.9 30-Day Fills standardized to 30-day supplies 1,337 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 33 | $18.77▼ below NY avg | ▼ Less than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 33 Medicare prescriptions for Dorzolamide-Timolol, about a third of the volume of the typical New York prescriber of this medication (90). Medicare paid an average of $18.77 per fill, versus $32.93 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 48.4 30-Day Fills standardized to 30-day supplies 1,450 Days of Medication total across all patients in 2023 | |||
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 26 | $8.76 | ▼ Less than typical |
About Polymyxin B Sul-Trimethoprim: This medication is used to treat bacterial infections (such as blepharitis, conjunctivitis) of the eye. Show more ▾ It contains 2 antibiotics. Polymyxin B works by killing the bacteria. Trimethoprim works by stopping the growth of the bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. In 2023, this provider wrote 26 Medicare prescriptions for Polymyxin B Sul-Trimethoprim, about 70% of the volume of the typical New York prescriber of this medication (37). Medicare paid an average of $8.76 per fill, versus $8.59 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 33.3 30-Day Fills standardized to 30-day supplies 909 Days of Medication total across all patients in 2023 | |||
| Difluprednate | 21 | $95.46▼ below NY avg | ▼ Less than typical |
About Difluprednate: This medication is used to treat swelling and pain after eye surgery. Show more ▾ It may also be used to treat a certain serious eye problem (endogenous anterior uveitis). This medication belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 21 Medicare prescriptions for Difluprednate, about half the volume of the typical New York prescriber of this medication (40). Medicare paid an average of $95.46 per fill, versus $152.51 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 25.7 30-Day Fills standardized to 30-day supplies 675 Days of Medication total across all patients in 2023 | |||
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 19 | $9.89▼ below NY avg | ▼ Less than typical |
About Neomycin-Polymyxin-Dexameth: This medication is used to treat conditions involving swelling (inflammation) of the eyes and to treat or prevent bacterial eye infections. Show more ▾ This product contains neomycin and polymyxin, antibiotics that work by stopping the growth of bacteria. It also contains dexamethasone, an anti-inflammatory corticosteroid that works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections and may worsen them (such as infections caused by viruses, fungi, mycobacteria). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. In 2023, this provider wrote 19 Medicare prescriptions for Neomycin-Polymyxin-Dexameth, about a third of the volume of the typical New York prescriber of this medication (49). Medicare paid an average of $9.89 per fill, versus $14.55 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 19.2 30-Day Fills standardized to 30-day supplies 383 Days of Medication total across all patients in 2023 | |||
| RhopressaNetarsudil Mesylate | 15 | $342.78▼ below NY avg | ▼ Less than typical |
About Rhopressa: Netarsudil is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ This medication is thought to work by increasing the flow of fluid out of the eye. This helps lower pressure inside the eye. Lowering high pressure inside the eye can help prevent loss of vision or blindness. In 2023, this provider wrote 15 Medicare prescriptions for Rhopressa, about a third of the volume of the typical New York prescriber of this medication (49). Medicare paid an average of $342.78 per fill, versus $467.97 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 15 30-Day Fills standardized to 30-day supplies 375 Days of Medication total across all patients in 2023 | |||
| Restasis MultidoseCyclosporine | 14 | $705.51▼ below NY avg | ▼ Less than typical |
About Restasis Multidose: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. In 2023, this provider wrote 14 Medicare prescriptions for Restasis Multidose, about half the volume of the typical New York prescriber of this medication (24). Medicare paid an average of $705.51 per fill, versus $875.28 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 14 30-Day Fills standardized to 30-day supplies 406 Days of Medication total across all patients in 2023 | |||
| Dorzolamide Hcl | 13 | $16.77▼ below NY avg | ▼ Less than typical |
About Dorzolamide Hcl: Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 13 Medicare prescriptions for Dorzolamide Hcl, about a quarter of the volume of the typical New York prescriber of this medication (48). Medicare paid an average of $16.77 per fill, versus $30.75 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 21.2 30-Day Fills standardized to 30-day supplies 631 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. GARETH M. C. LEMA MD, PHD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Retina Specialist prescribing approach at this New York, NY practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among NY prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
